[引用][C] Safety and efficacy of combined cardiac resynchronization therapy and implantable cardioversion defibrillationin patients with advanced chronic heart failure …

JB Young - JAMA, 2003

Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study

FA Masoudi, X Mi, LH Curtis, PN Peterson… - Annals of internal …, 2014 - acpjournals.org
Background: Trials comparing implantable cardioverter-defibrillator (ICD) therapy with
cardiac resynchronization therapy with a defibrillator (CRT-D) are limited to selected patients …

Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT

A Barsheshet, I Goldenberg, AJ Moss… - European heart …, 2011 - academic.oup.com
Aims There are no data regarding the differential response to cardiac resynchronization
therapy with defibrillator (CRT-D) by the aetiology of cardiomyopathy in mildly symptomatic …

Cardiac resynchronization and quality of life in patients with minimally symptomatic heart failure

PJ Veazie, K Noyes, Q Li, WJ Hall, A Buttaccio… - Journal of the American …, 2012 - jacc.org
Objectives: This study compared the quality of life (QOL) of patients with cardiac
resynchronization therapy (CRT) and an implantable cardioverter-defibrillator (ICD) to …

The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator

G Yao, N Freemantle, MJ Calvert, S Bryan… - European heart …, 2007 - academic.oup.com
Aims Cardiac resynchronization therapy (CRT-P) is an effective treatment for patients with
heart failure and cardiac dyssynchrony with moderate or severe symptoms despite …

An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with …

JG Cleland, WT Abraham, C Linde… - European heart …, 2013 - academic.oup.com
Aims Cardiac resynchronization therapy (CRT) with or without a defibrillator reduces
morbidity and mortality in selected patients with heart failure (HF) but response can be …

Ventricular resynchronization: current state of the art

C Leclercq, JM Hare - Circulation, 2004 - Am Heart Assoc
To date, 3 placebo control studies have been published, as follows: PAcing THerapies for
Congestive Heart Failure (PATH-CHF), MUltisite STimulation In Cardiomyopathy (MUSTIC) …

Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart …

V Kutyifa, L Geller, P Bogyi, E Zima… - European journal of …, 2014 - Wiley Online Library
Aims There are limited and contradictory data on the effects of CRT with implantable
cardioverter defibrillator (CRT‐D) on mortality as compared with CRT with pacemaker (CRT …

Benefit of combined resynchronization and defibrillator therapy in heart failure patients with and without ventricular arrhythmias

C Ypenburg, L van Erven, GB Bleeker, JJ Bax… - Journal of the American …, 2006 - jacc.org
Objectives: We attempted to assess the efficacy of combined cardiac resynchronization
therapy-implantable cardioverter-defibrillator (CRT-ICD) in heart failure patients with and …

The impact of left ventricular size on response to cardiac resynchronization therapy

J Rickard, DM Brennan, DO Martin, E Hsich… - American heart …, 2011 - Elsevier
Patients with nondilated (NDCM) or severely dilated cardiomyopathies (SDCM) have been
underrepresented in clinical trials of cardiac resynchronization therapy (CRT). We examined …